Related references
Note: Only part of the references are listed.The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy
Yongchang Lai et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response
Fei-Fei Hu et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794
Yu-Long Lan et al.
CELL PROLIFERATION (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Individualizing Systemic Therapies in First Line Treatment and beyond for Advanced Renal Cell Carcinoma
Yasir Khan et al.
CANCERS (2020)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
T-lymphocyte Kv13 channel activation triggers the NLRP3 inflammasome signaling pathway in hypertensive patients
Jian Zhu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma
Timothy J. Williamson et al.
BJU INTERNATIONAL (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
Catherine Sautes-Fridman et al.
FRONTIERS IN IMMUNOLOGY (2016)
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Senbabaoglu et al.
GENOME BIOLOGY (2016)
Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
N. Hiraoka et al.
BRITISH JOURNAL OF CANCER (2015)
High Expression of KCa3.1 in Patients with Clear Cell Renal Carcinoma Predicts High Metastatic Risk and Poor Survival
Maj Rabjerg et al.
PLOS ONE (2015)
KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma
Zhongqiang Guo et al.
TUMOR BIOLOGY (2015)
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
Claire Germain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Tertiary lymphoid structures in cancer and beyond
Marie-Caroline Dieu-Nosjean et al.
TRENDS IN IMMUNOLOGY (2014)
Current and future systemic treatments for renal cell carcinoma
Rosalie Fisher et al.
SEMINARS IN CANCER BIOLOGY (2013)
Quantitative proteomic Isotope-Coded Protein Label (ICPL) analysis reveals alteration of several functional processes in the glioblastoma
Emmanuelle Com et al.
JOURNAL OF PROTEOMICS (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Massimo D’Amico et al.
Recent Patents on Anti-Cancer Drug Discovery (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The Epidemiology of Renal Cell Carcinoma
Borje Ljungberg et al.
EUROPEAN UROLOGY (2011)
Na+/K+-ATPase α3 mediates sensitivity of hepatocellular carcinoma cells to bufalin
Huaxing Li et al.
ONCOLOGY REPORTS (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes
Lina Hu et al.
JOURNAL OF IMMUNOLOGY (2007)
Cardiotonic steroids on the road to anti-cancer therapy
Tajana Mijatovic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
K+ channel blockers: Novel tools to inhibit T cell activation leading to specific immunosuppression
G. Panyi et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines
A Masi et al.
BRITISH JOURNAL OF CANCER (2005)
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain
H Rus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
KV1.1 K+ channels identification in human breast carcinoma cells:: Involvement in cell proliferation
H Ouadid-Ahidouch et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
